Previous studies have established its role in post-translational modification of metabolic enzymes including PFKFB3, PKM2, and PHGDH, which collectively promote de novo fatty acid biosynthesis in breast cancer models [36]. The gene discussed is PHGDH; the disease is breast carcinoma.